HTR3A and Cognitive impairment: Indeed, ondansetron, an antiemetic 5-HT3R antagonistrevealed positive effects as adjunctive therapy of schizophrenia,12,57 ameliorating both negative symptoms and cognitive decline in patients.In parallel, 5-HT6R antagonists have emerged as promisingtools to treat cognitive impairment.